glp-1 news september 2025 Who Gets the Shot? Access by State Side Effects: Endocrine Society Journals

Costanza Alciati, a pharma analyst at GlobalData, told BioSpace in an email that GLP-1s will definitely dominate the market in the near future, but new entrants into the space are already looking for the next drug class that could revolutionize the space. Companies taking an alternative approach are forecast to capture only a very small portion of the obesity marketroughly 6.3%across the seven major markets (U.S., France, Germany, Italy, Spain, UK and Japan) by the end of 2031, according to Sara Reci, a senior analyst at GlobalData

PubMed Leyden J et al

Designed to promote healthy female arousal, it safely supports a vibrant female libido and deeper emotional connection without harsh stimulants RAPID AWAKENING: A refined female libido enhancer fast acting complex

Mitteilung: Klinische Anwendungen der ditetisch-hormonalen Krebsbeeinflussung (Entzuckerungsmethode)

Disorganized collagen remodeling: Collagen must be laid down and aligned under appropriate load